- Report
- July 2025
- 175 Pages
Global
From €3999EUR$4,490USD£3,470GBP
- Report
- June 2025
- 19 Pages
Global
From €13357EUR$14,995USD£11,589GBP
- Report
- August 2025
- 149 Pages
Global
From €2671EUR$2,999USD£2,318GBP
- Report
- August 2025
- 194 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- October 2025
- 185 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- October 2025
- 377 Pages
Global
From €5211EUR$5,850USD£4,521GBP
- Report
- August 2025
- 192 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- August 2025
- 185 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- July 2025
- 175 Pages
Global
From €3999EUR$4,490USD£3,470GBP
- Report
- October 2025
- 194 Pages
Global
From €3158EUR$3,545USD£2,740GBP
€3509EUR$3,939USD£3,044GBP
- Report
- October 2025
- 374 Pages
Global
From €5211EUR$5,850USD£4,521GBP
- Report
- October 2025
- 173 Pages
Global
From €5211EUR$5,850USD£4,521GBP
- Report
- March 2025
- 175 Pages
Global
From €3999EUR$4,490USD£3,470GBP
- Report
- January 2025
- 250 Pages
Global
From €4453EUR$4,999USD£3,864GBP
- Report
- May 2025
- 206 Pages
Global
From €4449EUR$4,995USD£3,860GBP
- Report
- November 2024
- 110 Pages
United States
From €5300EUR$5,950USD£4,598GBP
- Report
- December 2024
- 139 Pages
United States
From €2227EUR$2,500USD£1,932GBP
- Report
- February 2025
- 100 Pages
Middle East, Africa
From €3073EUR$3,450USD£2,666GBP
- Report
- February 2025
- 111 Pages
Asia Pacific
From €3073EUR$3,450USD£2,666GBP
- Report
- February 2025
- 111 Pages
Europe
From €3073EUR$3,450USD£2,666GBP

Multiple Sclerosis (MS) is a chronic, progressive neurological disorder that affects the central nervous system. It is classified as an autoimmune disorder, meaning that the body's immune system mistakenly attacks healthy tissue. MS is a major area of research within the field of Allergy and Immunology, as it is believed that the immune system plays a role in the development and progression of the disease. Treatment options for MS include medications, physical therapy, and lifestyle modifications.
MS is a major health concern, with an estimated 2.3 million people living with the condition worldwide. Symptoms of MS can vary greatly from person to person, and can include fatigue, vision problems, muscle spasms, and difficulty with balance and coordination.
Companies in the MS market include Biogen, Novartis, Sanofi, Merck, and Teva Pharmaceuticals. Show Less Read more